[NBY] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 78.81%
YoY- -1,466.67%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 3,727 3,255 4,610 3,124 3,643 3,826 3,045 14.38%
PBT -4,108 -1,757 -2,036 -1,739 -8,206 -136 -2,155 53.56%
Tax 302 -51 -256 5 -3,488 -321 3 2045.89%
NP -4,108 -1,757 -4,032 -1,739 -8,206 -5,793 -2,155 53.56%
Tax Rate - - - - - - - -
Total Cost 7,835 5,012 8,642 4,863 11,849 9,619 5,200 31.33%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -110.22 -53.98 -87.46 -55.67 -225.25 -151.41 -70.77 34.25%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -46.53 -13.11 -40.92 -23.13 -151.72 -126.40 -50.05 -4.73%
EPS Diluted -46.53 -13.11 -40.92 -23.13 -151.72 -126.40 -50.05 -4.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.